CTSH vs LYRA · P/E 12, rev $21.11B vs rev $1.5M
Cognizant Technology Solutions Corp Class A (CTSH) versus Lyra Therapeutics Inc (LYRA) — a side-by-side from cached financials, not a winner call.
Cognizant Technology Solutions Corp Class A (CTSH) is a information technology services company listed on US.
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
Latest reported CTSH revenue for 2025-12-31 was $21.11B. Net income was $2.23B. Revenue was up 7.0% from 2024-12-31 to 2025-12-31. CTSH currently screens at market cap $25.17B and trailing P/E 11.5.
Latest reported LYRA revenue for 2024-12-31 was $1.5M. Net income was -$93.4M. Revenue was down 1.5% from 2023-12-31 to 2024-12-31. LYRA currently screens at market cap $14.4M.
CTSH currently screens at market cap $25.17B and trailing P/E 11.5. LYRA currently screens at market cap $14.4M.
Not investment advice. Open the CTSH and LYRA stock pages for the full models.
Not investment advice.